Clinical trial
NIRS: a Tool for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients
NCT06243900 is registered in ClinicalTrials.gov with Yuanjun Yang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NIRS: a Tool for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients
- Lead sponsor
- Yuanjun Yang
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 15, 2024
- Completion date
- February 14, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease (esrd)